Assignee
METCELA INC
JP·2 granted patents·6 pending applications·0 citations·filing 2017–2022
Top patents by PatentIndex Score
8 records- 0150US11801267B2Cardiac cell culture materialMETCELA INC·Filed 2018·Granted Oct 31, 2023·0 cites·1 claims
- 0248US11096969B2Composition for injection which can be used for treatment of heart diseases and contains fibroblasts, and method for producing fibroblast for therapy useMETCELA INC·Filed 2019·Granted Aug 24, 2021·0 cites·5 claims
- 0346US2021254009A1Method for producing fibroblast, and g-csf-positive fibroblast massMETCELA INC·Filed 2021·Application pending·0 cites
- 0445US2021346436A1Composition for injection which can be used for treatment of heart diseases and contains fibroblasts, and method for producing fibroblast for therapy useMETCELA INC·Filed 2021·Application pending·0 cites
- 0543US2024316113A1Fibroblast-containing pharmaceutical composition for treating kidney diseaseMETCELA INC·Filed 2022·Application pending·0 cites
- 0642US2022411761A1Fibroblast having enhanced erythropoietin production abilityMETCELA INC·Filed 2022·Application pending·0 cites
- 0738US2024148795A1Lymphangiogenesis promoting factor-expressing fibroblast, and pharmaceutical composition containing sameMETCELA INC·Filed 2022·Application pending·0 cites
- 0835US2017112880A1Cardiac cell culture materialMETCELA INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when METCELA INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →